Please login to the form below

Not currently logged in
Email:
Password:

Beleodaq

This page shows the latest Beleodaq news and features for those working in and with pharma, biotech and healthcare.

AZ signs two more deals in cancer immunotherapy

AZ signs two more deals in cancer immunotherapy

The latter is in the same class as Merck &Co's Zolinza (vorinostat), Novartis' Farydak (panobinostat) and Spectrum Pharmaceuticals' Beleodaq (belinostat), which are approved for various haematological cancers.

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics